OncoLens - About the company
OncoLens is a series B company based in Atlanta (United States), founded in 2015 by Lijo Simpson and Anju Mathew. It operates as a Provider of a mobile and web-based platform for connecting oncologists. OncoLens has raised $27.1M in funding from investors like BIP Ventures, Atlanta Technology Angels and Martin Ventures. The company has 189 active competitors, including 19 funded and 15 that have exited. Its top competitors include companies like Medshr, Curofy and Liangyihui.
Company Details
OncoLens is a HIPAA compliant mobile and web-based platform for connecting oncologists. The platform enables physicians to create a tumor board and also allows them and other care providers to discuss and develop treatment plans for their cancer patients in real-time. OncoLens also enables the discussion of cases among colleagues and care teams without the involvement of a tumor board. Through the engagement of clinical trial researchers, cases can be identified early on as potential candidates for clinical trials.
- Website
- www.oncolens.com/
- Social
- Email ID
- *****@oncolens.com
Key Metrics
Founded Year
2015
Location
Atlanta, United States
Stage
Series B
Total Funding
$27.1M in 4 rounds
Latest Funding Round
Investors
Ranked
1st among 189 active competitors
Employee Count
33 as on May 31, 2026
Legal entities associated with OncoLens
OncoLens is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
LYNKCARE, INC. CIN: 7268115 , United States, Active | Feb 05, 2019 | - | 35 (As on Dec 31, 2023) | - |
Sign up to download OncoLens' company profile
OncoLens's funding and investors
OncoLens has raised a total funding of $27.1M over 4 rounds. Its first funding round was on Mar 26, 2019. Its latest funding round was a Series B round on Oct 02, 2024 for $*****. 4 investors participated in its latest round. OncoLens has 6 institutional investors.
Here is the list of recent funding rounds of OncoLens:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 02, 2024 | 8942062 | Series B | 6366735 | 2187988 | 3058155 | 1009293 |
Jan 13, 2021 | 2217780 | Series A | 5625232 | 6652364 | 3987154 | 5684348 |
Jan 06, 2020 | 6154352 | Seed | 5239933 | 5107732 |
Access funding benchmarks and valuations. Sign up today!View details of OncoLens's funding rounds and investors
OncoLens' founders and board of directors
Founder? Claim ProfileHere are the details of OncoLens' key team members:
- Lijo Simpson: Co-Founder of OncoLens. Contact Info: 1 email address
- Anju Mathew: Co-Founder & CEO of OncoLens. Contact Info: 1 email address
View details of OncoLens's Founder profiles and Board Members
OncoLens' employee count trend
OncoLens has 33 employees as of May 26. Here is OncoLens's employee count trend over the years:
Uncover OncoLens' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
OncoLens's Competitors and alternates
Top competitors of OncoLens include Medshr, Curofy and Liangyihui. Here is the list of Top 10 competitors of OncoLens, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | OncoLens 2015, Atlanta (United States), Series B | Provider of a mobile and web-based platform for connecting oncologists | $27.1M | 48/100 | |
2nd | Medshr 2013, London (United Kingdom), Seed | Knowledge sharing platform for Physicians | $1.89M | 48/100 | |
3rd | Online professional network of doctors for communication and patient referrals | $1.44M | 47/100 | ||
4th |  Liangyihui 2015, Shanghai (China), Series C | Medical information platform for cancer | $17.1M | 44/100 | |
5th |  Primum 2021, New York City (United States), Seed | Network of oncologists providing peer-to-peer expert consultation. It connects oncologists with specialists in various subfields of oncology to facilitate collaboration on complex cases. The platform allows for quick access to expert opinions and guidance, improving treatment decision-making. This model aims to enhance patient care by leveraging the collective knowledge and experience within the oncology community. The network facilitates knowledge sharing and helps oncologists stay abreast of the latest advancements in the field. | - | 43/100 | |
6th | Provider of social discussion platform for physicians | $9.96M | 42/100 | ||
7th | Meroka 2023, Wilmington (United States), Seed | Facilitator of employee-owned medical practice transitions | $6M | 40/100 | |
8th |  Meperia 2009, Santa Fe (United States), Acquired | Provider of supply chain content management and procurement solutions for healthcare organizations | - | - | 40/100 |
9th | The Rounds 2012, Halifax (Canada), Series A | Provider of HIPAA and PIPEDA-compliant online network for physicians | $7.8M | 40/100 | |
10th |  NHS Supply Chain 2019, London (United Kingdom), Unfunded | Manager of sourcing, delivery, and supply of healthcare products and services | - | - | 39/100 |
_1551878373137.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on OncoLens's competitors? Click here to see the top ones
OncoLens's Investments and acquisitions
OncoLens has made no investments or acquisitions yet.
Reports related to OncoLens
Here is the latest report on OncoLens's geography:
News related to OncoLens
Filter this list•
•
•
•
•
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about OncoLens
Explore our recently published companies
